Successful T-cell Replete Hematopoietic Stem Cell Boost Without Conditioning for Late Graft Failure
Y Tsutsumi1, T Tateno1, S Ito1
1Department of Hematology, Hakodate Municipal Hospital, Hakodate, Japan.
Transplantation Proceedings
|December 10, 2016
Summary
Late graft failure after allogeneic stem cell transplant can be treated with a stem cell boost without conditioning. This approach led to rapid engraftment and resolved infections, offering a new therapeutic option.
Area of Science:
- Hematology
- Immunology
- Transplantation
Background:
- Allogeneic stem cell transplantation (ASCT) is a curative therapy for hematologic malignancies.
- Late graft failure is a rare but serious ASCT complication, often associated with severe infections.
- Managing graft failure typically involves complex protocols and carries significant risks.
Observation:
- A patient experiencing late graft failure post-ASCT presented with persistent, severe infections.
- Standard treatments for graft failure and infection were ineffective.
- The patient's immunosuppression and nilotinib were discontinued to suppress host cells.
Findings:
- A T-cell replete hematopoietic stem cell boost without conditioning was administered.
- This intervention resulted in rapid donor engraftment.
- The patient achieved full donor chimerism, leading to the resolution of severe infections.
Implications:
- This case demonstrates the efficacy of a conditioning-free stem cell boost for late graft failure.
- Suppression of host cells via immunosuppressant and nilotinib withdrawal is crucial for successful boosting.
- This strategy offers a potentially safer and effective alternative for managing ASCT graft failure and associated infections.
Related Concept Videos
Bone Marrow Sampling and Transplants
2.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.1K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Tissue Transplantation
1.1K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Cell-mediated Immune Responses
85.5K
Overview
85.5K


